Literature DB >> 3356698

NMR study of a lymphocyte differentiating thymic factor. An investigation of the Zn(II)-nonapeptide complexes (thymulin).

M T Cung1, M Marraud, P Lefrancier, M Dardenne, J F Bach, J P Laussac.   

Abstract

Detailed investigations of a serum peptide (less than Glu1-Ala2-Lys3-Ser4-Gln5-Gly6-Gly7-Ser8-++ +Asn9) were carried out by 1H and 13C NMR spectroscopy to elucidate the structure of the complex formed with Zn(II), thymulin, which has been found to be active in vivo. These experiments were performed in dimethyl sulfoxide-d6 solution at different metal:peptide ratios. The results suggest the following conclusions. (i) The Zn(II) complexation corresponds to a fast exchange on the NMR time scale. (ii) The evolution of 1H and 13C NMR chemical shifts indicates the existence of two types of complexes: a 1:2 species associating two peptide molecules and one Zn(II) ion and a complex with 1:1 stoichiometry. The former is predominant for metal:peptide ratios below unity. (iii) In the 1:2 complex, Zn(II) is coordinated by the Ser4-O gamma H and Asn9-CO2- sites, while in the 1:1 complex, Ser8-O gamma H is the third ligand to the Zn(II) ion. The results are compared with those for the [Ala4] and [Ala8] analogues, and those for the complexes of thymulin with other metal ions (Cu2+ and Al3+) in terms of its biological activity. These comparative studies suggested that the 1:1 complex is the only conformation recognized by the antibodies.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3356698

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  4 in total

1.  Thymulin-based gene therapy and pituitary function in animal models of aging.

Authors:  Paula C Reggiani; Brenda Poch; Gloria M Cónsole; Omar J Rimoldi; Jose I Schwerdt; Victoria Tüngler; Margarita M Garcia-Bravo; Mireille Dardenne; Rodolfo G Goya
Journal:  Neuroimmunomodulation       Date:  2011-09-22       Impact factor: 2.492

Review 2.  Thymulin, a zinc-dependent hormone.

Authors:  J F Bach; M Dardenne
Journal:  Med Oncol Tumor Pharmacother       Date:  1989

3.  Thymulin gene therapy prevents the reduction in circulating gonadotropins induced by thymulin deficiency in mice.

Authors:  Rodolfo G Goya; Paula C Reggiani; Silvan M Vesenbeckh; Jean M Pléau; Yolanda E Sosa; Gloria M Cónsole; Rüdiger Schade; Peter Henklein; Mireille Dardenne
Journal:  Am J Physiol Endocrinol Metab       Date:  2007-03-27       Impact factor: 4.310

Review 4.  The thymus-neuroendocrine axis: physiology, molecular biology, and therapeutic potential of the thymic peptide thymulin.

Authors:  Paula C Reggiani; Gustavo R Morel; Gloria M Cónsole; Claudio G Barbeito; Silvia S Rodriguez; Oscar A Brown; Maria Jose Bellini; Jean-Marie Pléau; Mireille Dardenne; Rodolfo G Goya
Journal:  Ann N Y Acad Sci       Date:  2009-02       Impact factor: 5.691

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.